Observational Study
Copyright ©The Author(s) 2022.
World J Cardiol. Jul 26, 2022; 14(7): 411-426
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.411
Table 3 Hazard ratios of serum 25 hydroxyvitamin D concentration and metabolic syndrome for heart disease, cerebrovascular disease, cardiovascular disease, and all-cause mortality
Model 1
Model 2
HR
(95%CI)
P value
HR
(95%CI)
P value
Ref to 25(OH)D ≥ 30 ng/dL
25(OH)D for HD
20-291.13(0.82-1.55)0.451.13(0.83-1.52)0.43
< 201.54(1.14-2.08)0.0051.43(1.07-1.91)0.017
25(OH)D for CBVD
20-290.97(0.61-1.53)0.880.98(0.62-1.56)0.94
< 201.15(0.58-2.26)0.691.14(0.58-2.25)0.69
25(OH)D for CVD
20-291.09(0.82-1.46)0.541.10(0.82-1.46)0.52
< 201.44(1.09-1.91)0.0111.36(1.04-1.78)0.028
25(OH)D for all-cause mortality
20-291.16(0.99-1.35)0.061.16(0.99-1.36)0.07
< 201.38(1.16-1.64)0.0011.32(1.10-1.58)0.004
Ref to Non-MetS
MetS for HD1.31(1.09-1.58)0.0051.22(1.00-1.49)0.053
MetS for CBVD1.58(0.94-2.66)0.0831.60(0.96-2.65)0.069
MetS for CVD1.37(1.12-1.66)0.0021.29(1.05-1.59)0.017
MetS for all-cause mortality1.22(1.08-1.37)0.0021.20(1.05-1.36)0.008
Interaction of
25(OH)D x MetS on
HD0.91(0.72-1.17)0.460.91(0.72-1.15)0.41
CBVD0.80(0.39-1.66)0.540.79(0.38-1.62)0.50
CVD0.89(0.71-1.12)0.310.88(0.70-1.11)0.28
All-cause0.98(0.84-1.14)0.780.96(0.82-1.13)0.63